This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 1998 Jan 29;338(5):323-5.

doi: 10.1056/NEJM199801293380610.

Demyelinating diseases--new pathological insights, new therapeutic targets

PMID: 9445415
DOI: 10.1056/NEJM199801293380610

Editorial

Demyelinating diseases--new pathological insights, new therapeutic targets

S G Waxman. N Engl J Med. 1998.

. 1998 Jan 29;338(5):323-5.

doi: 10.1056/NEJM199801293380610.

Author

PMID: 9445415
DOI: 10.1056/NEJM199801293380610

No abstract available

PubMed Disclaimer

Comment on

Axonal transection in the lesions of multiple sclerosis.
Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mörk S, Bö L. Trapp BD, et al. N Engl J Med. 1998 Jan 29;338(5):278-85. doi: 10.1056/NEJM199801293380502. N Engl J Med. 1998. PMID: 9445407

Similar articles

Axonal damage in multiple sclerosis: a complex issue in a complex disease.
Grigoriadis N, Ben-Hur T, Karussis D, Milonas I. Grigoriadis N, et al. Clin Neurol Neurosurg. 2004 Jun;106(3):211-7. doi: 10.1016/j.clineuro.2004.02.017. Clin Neurol Neurosurg. 2004. PMID: 15177770 Review.
Multiple sclerosis--the plaque and its pathogenesis.
Frohman EM, Racke MK, Raine CS. Frohman EM, et al. N Engl J Med. 2006 Mar 2;354(9):942-55. doi: 10.1056/NEJMra052130. N Engl J Med. 2006. PMID: 16510748 Review. No abstract available.
Using stem cells in multiple sclerosis therapies.
Muraro PA, Cassiani-Ingoni R, Martin R. Muraro PA, et al. Cytotherapy. 2004;6(6):615-20. doi: 10.1080/14653240410005311. Cytotherapy. 2004. PMID: 15764028
Axon loss in multiple sclerosis.
Scolding N, Franklin R. Scolding N, et al. Lancet. 1998 Aug 1;352(9125):340-1. doi: 10.1016/S0140-6736(05)60463-1. Lancet. 1998. PMID: 9717917 No abstract available.
The pathogenesis and basis for treatment in multiple sclerosis.
Compston A. Compston A. Clin Neurol Neurosurg. 2004 Jun;106(3):246-8. doi: 10.1016/j.clineuro.2004.02.007. Clin Neurol Neurosurg. 2004. PMID: 15177777

See all similar articles

Cited by

Thyroid hormone alleviates demyelination induced by cuprizone through its role in remyelination during the remission period.
Zhang M, Zhan XL, Ma ZY, Chen XS, Cai QY, Yao ZX. Zhang M, et al. Exp Biol Med (Maywood). 2015 Sep;240(9):1183-96. doi: 10.1177/1535370214565975. Epub 2015 Jan 10. Exp Biol Med (Maywood). 2015. PMID: 25577802 Free PMC article.
Abnormal Purkinje cell activity in vivo in experimental allergic encephalomyelitis.
Saab CY, Craner MJ, Kataoka Y, Waxman SG. Saab CY, et al. Exp Brain Res. 2004 Sep;158(1):1-8. doi: 10.1007/s00221-004-1867-4. Epub 2004 Apr 29. Exp Brain Res. 2004. PMID: 15118796
Potassium channel blockers as an effective treatment to restore impulse conduction in injured axons.
Shi R, Sun W. Shi R, et al. Neurosci Bull. 2011 Feb;27(1):36-44. doi: 10.1007/s12264-011-1048-y. Neurosci Bull. 2011. PMID: 21270902 Free PMC article. Review.
Coherent anti-Stokes Raman scattering imaging of myelin degradation reveals a calcium-dependent pathway in lyso-PtdCho-induced demyelination.
Fu Y, Wang H, Huff TB, Shi R, Cheng JX. Fu Y, et al. J Neurosci Res. 2007 Oct;85(13):2870-81. doi: 10.1002/jnr.21403. J Neurosci Res. 2007. PMID: 17551984 Free PMC article.
Immunopathogenesis of multiple sclerosis.
Racke MK. Racke MK. Ann Indian Acad Neurol. 2009 Oct;12(4):215-20. doi: 10.4103/0972-2327.58274. Ann Indian Acad Neurol. 2009. PMID: 20182567 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information